Aminoglycosides and uses thereof in the treatment of genetic disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 25, 2018
Grant Date -
Mar 8, 2018
app pub date -
Nov 20, 2017
filing date -
Apr 3, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully